The Single Anastomosis, 300 cm Loop, Duodenal Switch (SIPS) Results in Less Nutritional Deficiencies Than the Standard Duodenal Switch (DS) Operation: A Multicenter, Randomized Controlled Trial
The aim of this study is to answer the question of whether the single anastomosis, 300 cm loop, duodenal switch (SIPS) is an equally effective, safe, simpler operation with less nutritional and surgical risks than the standard duodenal switch (DS) operation. Please note, this study does not provide a stipend or coverage for surgery.
A Randomized Phase II Study of Subventricular Zone (SVZ) Irradiation Plus Temozolomide in Newly Diagnosed Glioblastoma Multiforme
In this study patients will be treated with 6 weeks of radiation therapy plus temozolomide chemotherapy according to the standard of care. However, the radiation treatment plan will be modified to deliver an higher than routine radiation dose to the subventricular zone which is an area of the brain that contains stem cells that some scientists believe may contribute to glioblastoma recurrence. The purpose of the study is to see if the tumor is controlled for a longer period of time in patients treated with this modified radiation technique than it is in patients treated with standard radiation therapy plus temozolomide chemotherapy.
Cystic Lymphangiomas: Unusual Findings Resulting in Common General Surgery Presentations
4区 · 医学
Article
作者: Bamberger, P. Kurt ; Fluke, Laura M.
2018-03-01·Journal of the American College of Cardiology
PREVALENCE OF ACUTE VENOUS THROMBOEMBOLISM IN PATIENTS ADMITTED WITH HEART FAILURE IN THE UNITED STATES: ANALYSIS FROM NATIONAL INPATIENT SAMPLE 2004-2013
作者: Anthony Donato ; Sijan Basnet ; Rashmi Dhital ; Dilli R. Poudel
Venous thromboembolism (VTE) is the third most common cause of cardiovascular death after stroke and heart attack. It affects over 350,000 people and is responsible for more than 100,000 deaths each year. Heart failure (HF) has been identified as a major risk factor for VTE. Patients with HF are
2017-01-17·Annals of Internal Medicine1区 · 医学
Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV risk
1区 · 医学
Article
作者: Donato, Anthony A.
Source Citation Marso SP, Bain SC, Consoli A, et al; SUSTAIN-6 Investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016. [Epub ahead of print]. 27...